Celltrion Inc. posted preclinical study results of two new antibody-drug conjugate (ADC) candidates – CT-P70 and CT-P71 – at ...

Mainak Bhaumik reveals the motion poster for Bhaggyo Lokkhi, a thriller about a middle-class couple drawn into heroin ...

Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall acceptable safety profile observed so far and initial ...

Warren Central Elementary School’s Red Ribbon Week coloring and poster contest concluded last week with one winner per grade ...

2 Non-stimulant ADHD medications of different classifications work in different ways. Both Alpha-2 adrenergic agonists and SNRIs affect norepinephrine (or noradrenaline) levels in the nervous ...

Viking Therapeutics Inc (NASDAQ:VKTX) announced that new clinical data from the company’s VK2735 obesity program were ...

Drug driving, which is becoming a weapon on the road while the related laws are sluggish ... "I'm going to meet Kaplian all ...

An awareness program on drug abuse and its consequences was organized by the Swami Vivekananda Seva Brigade, in collaboration ...

today reported preclinical results on potential synergism between nadunolimab and antibody-drug conjugate (ADC) therapies.

Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III Session Date: Monday ... from Protagonist's proprietary discovery platform are in advanced Phase 3 clinical development, with ...

Ichnos Glenmark Innovation's cancer drug ISB 2001 shows promising results in Phase 1 trial, to be presented at ASH.